v3.26.3
DESCRIPTION OF BUSINESS (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 08, 2026
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
product
Sep. 30, 2025
USD ($)
Oct. 30, 2026
$ / shares
Feb. 28, 2025
Business Combination [Line Items]              
Acquisition-related expenses   $ 7,384 $ 0 $ 7,384 $ 0    
Revenue | Product              
Business Combination [Line Items]              
Concentration of products (in products) | product       2      
GQ Bio Therapeutics GmbH              
Business Combination [Line Items]              
Percentage of voting interests acquired             81.00%
Indemnification holdback release       $ 6,300      
Indemnification holdback period       18 months      
Acquisition-related expenses       $ 2,200      
Viatris Inc.              
Business Combination [Line Items]              
Acquisition-related expenses   $ 7,400   7,400      
Viatris Inc. | Subsequent Event              
Business Combination [Line Items]              
Offer price of share (in dollars per share) | $ / shares           $ 36.50  
Ownership waiver threshold           50.00%  
Termination fees $ 62,000            
Viatris Inc. | Scenario, Plan              
Business Combination [Line Items]              
Acquisition-related expenses       $ 40,000